Hi jesse. You may call me wj. Of course you're not all wrong, but you do tend to stretch it a little on occasion.
I didn't say GE would not like their money back, only that they would not suffer terribly if they do not get it.
If Leo's collaboration with GTC is not a loser, tell me how much profit Leo has made to this point.
Pharmathene may or may not make another transgenic protein, but at any rate their contract with GTC is over in a few months (sometime in the third quarter this year). I'll bet PIP is already making other arrangements for processing their product. However, if Protexia ia a commercial success, GTC (or its successor) WILL receive a royalty from the license.
The thing some of you guys don't seem to realize ... or want to admit ... is that a GTC bankruptcy will NOT cause all their assets to go poof. Someone else will pick up the pieces and deal with whoever is still interested ... like Merrimac for instance.
Just hope the GTC stockholders will get a few crumbs. That is not a slam dunk.
